ECMTB'26

ECMTB'26 has been a member of Linktree for less than a month and joined in July 2026. The social media accounts linked to from ECMTB'26 are: • LinkedIn • Email • Website Besides social media accounts, silviabordel has populated their site with: • Theranostic digital twins: Concept, framework and roadmap towards personalized radiopharmaceutical therapies • Radiopharmaceutical therapy for metastatic prostate cancer: Insights from mechanistic modeling and in silico trials | bioRxiv • José García Otero • Mathematic Modeling of Tumor Growth During [177Lu]Lu-PSMA Therapy: Insights into Treatment Optimization | Journal of Nuclear Medicine • Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes • Silvia Bordel-Vozmediano • The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates | European Journal of Nuclear Medicine and Molecular Imaging | Springer Nature Link • Matteo Italia • Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial • Víctor M. Pérez-García • [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study • Gabriel F. Calvo